The safety of agomelatine in standard medical practice in depressed patients: A 26‐week international multicentre cohort study

OBJECTIVE: The present observational cohort study documented the safety of agomelatine in current medical practice in out‐patients suffering from major depressive disorder. METHOD: The 6‐month evolution of agomelatine‐treated patients was assessed with a focus on safety (emergent adverse events, liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorwood, Philip, Benichou, Jacques, Moore, Nicholas, Álvarez Martínez, Enric, Mertens, Joost, Aguglia, Eugenio, Figueira, Maria‐Luisa, Falkai, Peter, Olivier, Valérie, Wattez, Marine, Picarel‐Blanchot, Françoise, de Bodinat, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816263/
https://www.ncbi.nlm.nih.gov/pubmed/32976677
http://dx.doi.org/10.1002/hup.2759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816263/
https://www.ncbi.nlm.nih.gov/pubmed/32976677
http://dx.doi.org/10.1002/hup.2759

Ejemplares similares